Neonatal Jaundice

Neonatal Jaundice

NEONATAL JAUNDICE Jaundice: yellowing of the skin, scleral, and mucous membranes from a build up of bilirubin. 60% of term infants and 80% of preterm infants develop jaundice in the 1st week of life, typically an unconjugated hyperbilirubinemia. SCREENING All infants in the first 24 hours of life: § Total serum bilirubin (TSB) § Transcutaneous bilirubin RISK FACTORS § Prematurity § Visible jaundice ≤ 24 § Cephalohematoma hours § Bruising § Visible jaundice before § Dehydration discharge at any age § Male sex § Exclusive and partial § Maternal age ≥ 25 breastfeeding § Asian or European § Sibling with severe descent hyperbilirubinemia UNCONJUGATED HYPERBILIRUBINEMIA – PHYSIOLOGIC JAUNDICE BREASTFEEDING JAUNDICE BREAST MILK JAUNDICE PREMATURITY § Early onset – 1st week after birth § Later onset – after 1st week of life § Occurs in preterm § Insufficient milk intake leads to § Bilirubin levels peak during weeks 2-3 of life infants (< 37 dehydration resulting in § Can persist for 3-12 weeks weeks) hemoconcentration of bilirubin § Cause unknown § More likely to § Fewer bowel movements increases the § It is thought that substances in breast milk require enterohepatic circulation of bilirubin interfere with the breakdown of bilirubin phototherapy MANAGEMENT § Phototherapy (use AAP normograms to determine the § Phototherapy makes bilirubin water soluble by need for phototherapy – based on TSB and age in hours) inducing a conformational change § Continue breastfeeding § Hyperbilirubinemia is treated to prevent § Supplemental PO or IV fluids (PO preferred over IV) kernicterus/acute bilirubin encephalopathy PATHOLOGIC UNCONJUGATED HYPERBILIRUBINEMIA CONJUGATED HYPERBILIRUBINEMIA HEMOLYTIC NON-HEMOLYTIC EXTRAHEPATIC INTRAHEPATIC INTRINSIC § Sepsis § Biliary atresia § Infections: hepatitis, § G6PD deficiency § Hypothyroidism § Choledochal cysts TORCH, UTI, etc. § Hereditary spherocytosis § Cephalohematoma § Perforated bile ducts § Drugs: eg. ceftriaxone, § Thalassemia § Gilbert § Tumour/mass sulfonamides, etc. § Crigler-Najjar § Cystic fibrosis § Genetic/metabolic: eg. EXTRINSIC § Galactosemia Alagille syndrome, etc. § Drugs Work-up: Coombs test, § Iso-immune (ABO, Rh) CBC with differential, blood Must rule out biliary atresia! § Sepsis smear, blood culture Initial investigation: abdominal ultrasound Published March 2021 Katharine V. Jensen (Medical Student 2021, University of Alberta) and Dr. Jillian Popel (Pediatrician & Clinical Lecturer of Pediatrics, University of Alberta) for www.pedscases.com.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    1 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us